EP3676261
Setnar 2-asabísýkló[3.1.1]heptan og 2-asabísýkló[3.2.1]oktan afleiður sem órexín viðtaka-mótlyf
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.8.2018EP published:
18.12.2024EP application number:
18766021.2
EP translation filed:
26.2.2025Grant published:
15.3.2025EPO information:
European Patent Register
Max expiry date:
30.8.2038Expiry date:
30.8.2026Next due date:
31.8.2026
Title in English:
SUBSTITUTED 2-AZABICYCLO[3.1.1]HEPTANE AND 2-AZABICYCLO[3.2.1]OCTANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTSLanguage of the patent:
English
Timeline
Today
31.8.2018EP application
18.12.2024EP Publication
26.2.2025Translation submitted
15.3.2025Registration published
30.8.2026Expires
Owner
Name:
Chronos Therapeutics LimitedAddress:
TheraCryf Plc Alderley Park Congleton Road, Nether Alderley SK10 4TG, GB
Inventor
Name:
MICHELI, FabrizioAddress:
37135 Verona, IT
Name:
BERTANI, BarbaraAddress:
37135 Verona, IT
Name:
GIBSON, Karl RichardAddress:
Sandwich Kent CT13 9FF, GB
Name:
DI FABIO, RomanoAddress:
20132 Milano, IT
Name:
RAVEGLIA, LucaAddress:
37135 Verona, IT
Name:
ZANALETTI, RiccardoAddress:
36075 Montecchio Maggiore VI, IT
Name:
CREMONESI, SusannaAddress:
37135 Verona, IT
Name:
POZZAN, AlfonsoAddress:
37135 Verona, IT
Name:
SEMERARO, TeresaAddress:
37135 Verona, IT
Name:
TARSI, LucaAddress:
37135 Verona, IT
Name:
LUKER, Timothy JonAddress:
Nottingham Nottinghamshire NG7 1GJ, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201714049Date:
1.9.2017Country:
GB
Number:
201804745Date:
23.3.2018Country:
GB
Classification
Categories:
C07D 401/14, C07D 413/14, C07D 401/10, C07D 417/06, C07D 417/10, C07D 417/14, C07D 471/04, C07D 487/04, C07D 498/04, C07D 513/04, A61K 31/439, A61P 25/30
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 20.8.2025
Expires: 30.8.2026
Payer: iPify